27th Annual Meeting and Education Day of the Society for Neuro-Oncology
November 17 - 20, 2022


              

This activity is jointly provided by Global Education Group and Society for Neuro-Oncology
This activity is supported by an educational grant from Medtronic, Inc

Target Audience
Neuro-oncologists (both neurology and medical oncology-trained), Medical Oncologists, Neurosurgeons, Neuro-radiologists, Neuropathologists, Neuropsychologists, Radiation Oncologists, Basic and Translational Scientists, Basic and Clinical Science Trainees, Allied Health Professionals, Palliative Care Professionals, Industry Professionals, Regulatory and Government Officials, Patient Advocates, and Nursing Professionals.

Statement of Need/Program Overview
The Society for Neuro- Oncology’s Annual Meeting is the largest and most influential meeting for multidisciplinary collaboration in the field of Neuro-Oncology. The latest advances in Central Nervous System (CNS) cancers are shared with an international audience that includes a variety of sub-specialties involved in basic & translational research, clinical as well as symptom management research. The meeting fosters opportunities to explore collaborations that will positively influence outcomes for patients with CNS cancers. This activity will be a collaboration of researchers and clinicians disseminating new knowledge to healthcare professionals in order to provide the highest quality of patient care to improve patient outcomes. The goal is to provide healthcare professionals with updated viewpoints, strategies, collaboration opportunities and an increased knowledge base to maximize treatment and management of brain tumor patients.

This year’s meeting will highlight the theme of Examining Tumors and their Environment to Improve Patient Care. We are thrilled to share that an outstanding group of plenary speakers have been confirmed.  As an adjunct to the main meeting, the Education Day on November 17 will feature two distinct tracks of specialized content.  The first track, organized by Michelle Monje, Humsa Venkatesh and Varun Venkataramani, will focus on Cancer Neuroscience.  The second track, organized by Milan Chheda, Mariella Filbin, Jennie Taylor and Jeffrey Wefel, will address CNS Cancer Survivorship. It is hoped that healthcare professionals will advance the treatment and management of CNS tumor patients.

The purpose of this conference is to provide those interested in the treatment and care of brain tumor patients with updated viewpoints and treatment strategies

Educational Objectives

• Discuss the basic concepts of how the nervous system and cancers form functional tumor networks.
• Identify the challenges of survivorship from scientific and psychosocial perspectives.
• Discuss multidisciplinary treatment and diagnostic advances in the management of adult and pediatric CNS tumors.
• Summarize unique issues in clinical trial design, delivery, and treatment for CNS tumors.
• Define health disparities and ethnic differences in outcomes for glioma patients.
• Identify new advances in the research and treatment of pediatric brain tumors.
• Discuss cutting-edge basic science research of adult and pediatric CNS tumors.

Faculty
Please click here to view the faculty. 

Program Agenda
Please click here to view the preliminary program.

Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Society for Neuro-Oncology. Global is accredited by the ACCME to provide continuing medical education for physicians.

Physician Credit Designation
Global Education Group designates this live activity for a maximum of *29.25 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education
Global Education Group is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

This educational activity for 29.25 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Global Contact Information
For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.

Instructions to Receive Credit
In order to receive credit for this activity, the participant must have attended the sessions in-person (you cannot claim CME for on-demand sessions), complete the overall program evaluation and session evaluations by logging in to this website or the conference mobile app by using the users registration login. 

For step-by-step instructions, click here. 

Deadline to claim CE Credit is Friday, March 3rd, 2023.

Refund/Cancellation Policy
The deadline for cancellations with refund is Thursday, November 3, 2022. Cancellations must be received in writing and a $50 cancellation fee will be assessed. Cancellations received after the deadline date cannot be refunded, but the meeting registration can be transferred to another person with written authorization.

Please note that your SNO membership must be current if you have chosen to register as a SNO member. SNO reserves the right to confirm that you have registered in the correct category.

Email all cancellation and transfer requests to Program Registrar Caroline Noor, caroline@soc-neuro-onc.org.
  
Disclosure of Conflicts of Interest
Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global.  All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias. 

All relevant financial relationships have been mitigated.

Disclosure list of all individuals in control of content for the program can be found by clicking here.

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and Society for Neuro-Oncology do not recommend the use of any agent outside of the labeled indications. 

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
 
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.